Inventor
YOUDIM MOUSSA B H
IL31 patents
⚠️ This page may combine multiple inventors who share the name “YOUDIM MOUSSA B H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEVA PHARMA
19 patentsUS5891923AApr 6, 1999
R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia
TEVA PHARMA97 citations99
US5519061AMay 21, 1996
R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
TEVA PHARMA139 citations99
US5457133AOct 10, 1995
R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them
TEVA PHARMA112 citations99
US6630514B2Oct 7, 2003
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TEVA PHARMA77 citations98
US5786390AJul 28, 1998
Pharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindan
TEVA PHARMA105 citations98
US5532415AJul 2, 1996
R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
TEVA PHARMA169 citations98
US5744500AApr 28, 1998
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TEVA PHARMA100 citations97
US5668181ASep 16, 1997
Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression
TEVA PHARMA92 citations97
US5599991AFeb 4, 1997
Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan
TEVA PHARMA84 citations97
US5576353ANov 19, 1996
Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
TEVA PHARMA101 citations97
US5453446ASep 26, 1995
Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.
TEVA PHARMA104 citations97
US6528685B2Mar 4, 2003
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA47 citations96
US6277886B1Aug 21, 2001
Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan
TEVA PHARMA66 citations96
US5914349AJun 22, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA50 citations96
US5877221AMar 2, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA52 citations96
US5994408ANov 30, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA54 citations95
US5880159AMar 9, 1999
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
TEVA PHARMA47 citations94
US6538025B2Mar 25, 2003
Aminoindan derivatives
TEVA PHARMA31 citations92
US6251938B1Jun 26, 2001
Phenylethylamine derivatives
TEVA PHARMA45 citations92
TECHNION RES & DEV FOUNDATION
3 patentsUS6316504B1Nov 13, 2001
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TECHNION RES & DEV FOUNDATION98 citations99
US6956060B2Oct 18, 2005
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
TECHNION RES & DEV FOUNDATION57 citations96
USRE39616EMay 8, 2007
Aminoindan derivatives
TECHNION RES & DEV FOUNDATION9 citations73
YOUDIM MOUSSA B H
3 patentsUS8685955B2Apr 1, 2014
Neuroprotective iron chelators and pharmaceutical compositions comprising them
YOUDIM MOUSSA B H2 citations58
US8097608B2Jan 17, 2012
Methods for treatment of cardiovascular disorders and diseases
YOUDIM MOUSSA B H1 citations39
US8802675B2Aug 12, 2014
Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
YOUDIM MOUSSA B H0 citations36